MedPath

The hypercapnic ventilatory response measured with a rebreathing and steady-state apparatus in healthy subjects

Completed
Conditions
gezonde proefpersonen
healthy
non-diseased
Registration Number
NL-OMON45318
Lead Sponsor
Medisch Spectrum Twente
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

between 18 and 65 years
written informed consent

Exclusion Criteria

history of cardiopulmonary disease, neuromuscular disease, kyphoscoliosis
drug abuse
use of respiratory stimulants or depressants
pregnancy
unable to understand english or dutch

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main study endpoint is the reproducibility of the measurements. This is<br /><br>calculated by means of the ICC between the CO2 sensitivity slope of the first<br /><br>and second measurement per method. Thus the ICC of S1R1-S1R2 and S1SS1-S1SS2.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary endpoints are:<br /><br>-The experiences of the subjects with both measurements<br /><br>- Duration of the measurements<br /><br>- Costs of the method (sum of the costs of the various part of each method +<br /><br>costs of one long function analyst performing the measurement)</p><br>
© Copyright 2025. All Rights Reserved by MedPath